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Abstract
Background: The objective of this study was to identify substantially increased proteins in bovine
cystic follicular fluid (FF) in order to clarify the pathology and etiology of bovine ovarian follicular
cysts (BOFC).
Methods: Proteins in normal and cystic FF samples were subjected to two-dimensional
polyacrylamide gel electrophoresis (2-D PAGE) and were compared using silver stained gel images
with PDQuest image analysis software. Peptides from these increased spots were analyzed by
matrix assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), and
were identified based on the NCBI database by a peptide mass fingerprinting method.
Results: Comparative proteomic analysis showed 8 increased protein spots present in cystic FF.
MS analysis and database searching revealed that the increased proteins in cystic FF were bovine
mitochondrial f1-atpase (BMFA), erythroid associated factor (EAF), methionine synthase (MeS),
VEGF-receptor, glyceraldehydes 3-phosphate dehydrogenase (GAPDH), heat shock protein 70
(HSP70), β-lactoglobulin (BLG) and succinate dehydrogenase Ip subunit (SD).
Conclusion: Our results suggest that these proteins are overexpressed in BOFC, and that they
may play important roles in the pathogenesis of BOFC. Furthermore, these proteins in the FF could
be useful biomarkers for BOFC.
Background
BOFC is one of the most frequently diagnosed gynecolog-
ical findings in cattle, and is a major reproductive prob-
lem in cows, causing infertility [1-3]. BOFC is generally
defined as follicle-like structures of greater than 25 mm in
diameter without a corpus luteum in both ovaries [1,4].
There have been several different hypotheses regarding
the cause of BOFC, such as inherited factors, high lacta-
tion, aging, seasonal effects, nutritional condition, envi-
ronmental estrogen and stress [1,2,4,5]. The primary
cause of BOFC development has not been elucidated
because of the variety of histological characteristics [1],
various abnormal hormonal patterns [1,4], and differing
therapeutic responses [1,4]. However, it is generally
believed that cysts are formed in response to an "endo-
crine imbalance" [3,4,6]. Several hypotheses have been
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mone (GnRH) and gonadotropin are implicated in the
pathogenesis of ovarian cysts. Actually, some authors
attribute the disease to alterations in synthesis and release
of GnRH [6,7], luteinizing hormone (LH) [7-9] or even to
a receptor deficiency at the pituitary level [10,11].
2-D PAGE, originally described by O'Farrell [12] in 1975,
is the method of choice for the separation of cell proteins,
where proteins are separated in two sequential steps. This
technique is an important proteomics tool, using which
many protein spots can be visualized, resulting in a global
view of a proteome's state [13]. Furthermore, recent devel-
opments in 2-D PAGE and mass spectrometry technolo-
gies have enabled quantitative analysis of differential
proteomics, such as a comparison between normal and
disease status, allowing identification of protein markers
to characterize a specific physiological or pathological cell
or tissue state [14,15] which have been used in the fields
of diagnosis and biomarker identification of animal and
human diseases [16,17].
As described above, research on BOFC has focused on
endocrinological conditions [6,8], but there are few
research reports on proteins in the FF of BOFC. Although
Mortarino et al. [18] published one short research report
about making a 2-D PAGE map of proteins expressed in
the FF of BOFC, they used a 2-D PAGE process using FF
which had not been depleted of abundant proteins such
as albumin or immunoglobulin G. Therefore, it was
thought that they overlooked spots of minor, but impor-
tant proteins. Muranaka et al. [19] also examined protein
in FF; the content of total protein in the FF of BOFC was
significantly lower than that of the FF of normal follicles.
This study was designed to determine any substantially
increased proteins in the FF from BOFC using a differen-
tial proteomics technique. The results help to clarify the
pathology and etiology of BOCF and will contribute to the
discovery of BOFC biomarkers.
Methods
Experimental design
This study consisted of the two following experimental
phases; 1) examination of protein sample preparations
from FF, and 2) assessment of increased proteins in the FF
of BOFC by 2-D PAGE.
Experiment 1: Examination protein sample preparation
Cystic follicles were collected from dairy cows at a local
slaughterhouse. FF was aspirated carefully with a 20 mL
syringe, and centrifuged at 10,000 × g at 4°C for 30 min-
utes to eliminate cells and other insoluble materials, and
stored at -30°C until processing for protein sample
preparation.
Three types of FF protein sample were prepared in order to
find an appropriate sample preparation method for 2-D
PAGE.
Type A: Non-treatment
Type B: Deplete impurities (salts, lipids, detergent or
nucleic acid)
Type C: Deplete both abundant proteins (albumin and
IgG) and impurities
A detailed sample preparation method for depletion of
both abundant proteins and impurities for Type C is
shown in the following section on "Sample preparation".
Non-depleted FF was used as Type A. Deplete impurities
from FF were used as Type B. Samples depleted of both
abundant proteins (albumin and IgG) and impurities
were used as Type C. These samples were subjected to 2-D
PAGE and silver stain gel images were compared visually.
Details of sample preparation, 2-D PAGE and silver stain-
ing are shown in the latter parts of this section.
Experiment 2: Assessment of increased proteins in the FF of 
BOFC
Ovaries with (n = 4) or without (n = 3) cystic follicles were
used in this experiment. A follicular cyst was diagnosed
when the follicle was greater than 25 mm in diameter in
the absence of a functional corpus luteum in both the
right and left ovaries [1]. Follicles of about 10 mm in
diameter from ovaries without cystic follicles were used as
large normal follicles. About 300 – 1000 µL of FF was
aspirated carefully from each follicle with a syringe. After
measureming progesterone and estradiol-17β in FF, FFs
from cystic follicles were stored individually and those
from normal follicles were pooled.
Each follicle was fixed in formalin after aspiration of FF,
processed for histological examination and stained with
hematoxylin and eosin using a standard method.
The FF protein samples were prepared by the Type C
method (depleted of both abundant proteins (albumin
and IgG) and impurities). Each sample from cystic folli-
cles with pooled control samples was simultaneously
processed for 2-D PAGE twice and gels were visualized by
silver staining. The stained gels were scanned using a desk-
top scanner and scanned images from cystic and normal
FFs were analyzed with PDQuest software version 7.1
(Bio-Rad Laboratories Inc., Hercules, USA). Expressions
of protein spots on the images from cystic and normal FFs
that were processed for 2-D PAGE simultaneously were
compared, and a overall comparison of the results from 4
cystic follicle images was made.Page 2 of 9
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excised from the silver stained gels and subjected to mass
spectrometry analysis and protein identification.
Details of each experimental process are given in the fol-
lowing section.
Enzyme immunoassay of progesterone and estradiol-17β 
in follicular fluid
The enzyme immunoassay procedure for progesterone
and estradiol-17β was followed as described previously
[20]. FF diluted with H2O was extracted with petroleum
ether for progesterone or diethylether for estradiol-17β.
The decanted ether phase was dried in a glass tube and a
buffer (0.05 mol/L boric acid, 0.2% BSA) was added.
These reconstituted samples were placed into wells of a
microtiterplate that was coated previously with an anti-
rabbit IgG antibody (ICN, Pharmaceuticals Inc., USA) fol-
lowed by the addition of an anti-progesterone antibody
and Horseradish peroxidase (HRP) conjugated progester-
one for progesterone, and an anti-estradiol-17β antibody
(Kambegawa Institute, Tokyo, Japan) and HRP conju-
gated estradiol-17β (Kambegawa Inst.) for estradiol-17.
After 2-h incubation plates were washed and a 3,3',5,5'-
Tetramethylbenzidine solution was applied to the sub-
strate followed by reading optical density measurement at
a wavelength of 450 nm.
Protein sample preparation
Initially, the total protein content in FF was determined
using a commercial protein assay kit (DC Protein Assay,
Bio-Rad laboratories Inc., Hercules, USA). After measur-
ing the protein content, high abundant proteins, albumin
and immunoglobulin G (IgG) were removed from FF
using an Aurum serum protein mini kit (Bio-Rad labora-
tories, Inc., Hercules, USA) to enable the visualization of
low abundant proteins. Then, proteins in depleted FF
samples were concentrated by centrifugation using a 3
kDa cut off cellulose membrane filter unit (Microcon YM-
3, Millipore, Bedford, USA). Finally, impurities such as
salts, lipids, detergent or nucleic acid were removed from
concentrated samples using a 2-D Clean-Up Kit (Amer-
sham Biosciences, San Francisco, USA).
2-D PAGE
Fifty µg of protein sample was dissolved in a sample
buffer (8 M urea, 0.5% ampholine ph3.5-10, 0.5% Triton
X-100, 10 mM dithiothreitol (DTT) and Orange G). The
sample buffer, including 50 µg protein, was absorbed into
an immobilized pH gradient (IPG) strip (Immobiline Dry
Strip, 11 cm, pH range 3–10, Amersham Biosciences,
Uppsala, Sweden) overnight. The rehydrated strip was
subjected to isoelectric focusing on a MultiPhor II electro-
phoresis chamber (Amersham Biosciences, Uppsala, Swe-
den) for a total of 22,651 Vh at 15°C. The focused IPG
strip was equilibrated in sodium dodecyl sulphate (SDS)
buffer (30% glycerol, 1.0% SDS and 6 M urea in 50 mM
Tris-HCl). The first equilibration step was carried out in
SDS equilibration buffer with 16 nM DTT, and the second
portion of the SDS equilibration buffer contained 240
mM iodoacetamide and bromophenol blue. Both equili-
bration steps lasted 15 min at room temperature. The
equilibrated IPG strip was placed onto an 8–18% gradient
polyacrylamide gradient gel (ExcelGel SDS, Amersham
Biosciences, Uppsala, Sweden) for second dimensional
SDS-PAGE. The SDS-PAGE was performed at 20 mA for 30
min, 50 mA for 5 min and 50 mA for 70 min at 15°C with
power supply limitation of 600 V and 30 W using a Mul-
tiPhor II electrophoresis chamber. After separation in
SDS-PAGE, the proteins on the gel were fixed and visual-
ized by silver staining using a Silver Stain Plus Kit (Bio-
Rad laboratories Inc., Hercules, USA).
Mass spectrometry analysis and protein identification
The spot was excised from the silver stained gel and then
digested with trypsin using a previously described method
[21]. For in-gel digestion, the pieces of gel were immersed
in 50% acetonitrile solution for 10 min and this process
was repeated several times. After washing with ace-
tonitrile, acetonitrile was removed and the gel pieces were
dried in a vacuum centrifuge for 10 min. The gel pieces
were shaken with 100 µL of reducing solution (10 mM
DTT and 25 mM ammonium bicarbonate) for 60 min at
56°C. Subsequently, the gel pieces were shaken under
dark conditions with 100µL of an alkylating solution (55
mM iodoacetamide and 25 mM ammonium bicarbonate)
for 45 min. The gel pieces were shaken with 50% ace-
tonitrile and 25 mM ammonium bicarbonate for 10 min
twice. The solvent was removed, and the gel pieces were
dried again. The gel pieces were then immersed in a diges-
tion solution containing 12.5 µg/mL sequencing grade
modified trypsin and 25 mM ammonium bicarbonate
and incubated on ice for 10 min. After removing unab-
sorbed solution, the gel pieces were incubated for 16 h at
37°C. Digested peptides were extracted twice from gel
pieces with 50 µL of 50% acetonitrile and 0.1% trifluoro-
acetic acid. The pooled supernatants were dried in a Speed
Vac, and the peptides were dissolved in 10 uL of 50% ace-
tonitrile with0.1% trifluoroacetic acid. MALDI-TOF MS
was performed on an Ultraflex time-of-flight instrument
(Bruker Daltonics, Billerica, USA) equipped with a nitro-
gen laser operating at 337 nm. All MALDI-TOF results
were obtained in the reflector-positive mode using α-
cyano-4-hydroxycinnamic acid (saturated solution in 50
% acetonitrile with 0.1% trifluoroacetic acid) as the
matrix. Analytes were prepared by mixing 0.5 µL of pep-
tide sample with 0.5 µL of matrix soln. on a MALDI plate
and allowed to air dry at room temperature in a hood
before inserting then into the spectrometer. Mass spectra
were calibrated with angiotensin II (1046.54 Da),Page 3 of 9
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bombesin (1619.82 Da), adrenocorticotropic hormone
(ACTH18-39) (2465.20 Da), and insulin (5733.54 Da).
All masses are reported as monoisotopic mass values. In
addition, peptides derived from trypsin (843.02 and
2212.44 Da) were used for validation when clearly
observed. Peptides were identified with the Mascot search
program (http://www.matrixscience.com, Matrix Science,
London, UK) against the NCBI database to perform theo-
retical trypsin digests and search for potentially unmodi-
fied tryptic peptides (with up to one missed cleavage) or
suspected modified species. Methionine residues were
considered as either normal Met or their oxidized form
(Met-ox), and cysteine residues were considered to be car-
bamidomethylated (C-cam) or reacted with acrylamide to
produce Cys-S-b-propionamide (C-pam).
Statistical analysis
Differences in the concentration of estradiol-17β and pro-
gesterone in follicular fluid, and the ratio of those hor-
mone concentrations between normal and cystic follicles
were analyzed by analysis of variance, followed by stu-
dent's t-test. Differences were considered significant at P <
0.05.
Results
Examination of protein sample preparation
2-D PAGE images of type A (non treatment), type B
(depleted of impurities) and type C (depleted of both
abundant proteins and impurities) are shown in Fig. 1.
Only large streaks and some spots were seen on the gel
image of type A. After removing impurities, such as salts,
lipids and nuclei acid, the large streaks disappeared, but
there were about 15 spots, including a large albumin spot,
on the gel image of type B. By removing both abundant
proteins and impurities, the image was improved, and
about 40 spots were visualized on the gel image of type C.
Assessment of increased proteins in the FF of BOFC
On histological examination, ovarian follicles from the
ovaries without cysts used as normal controls in this study
(Panel A in Figure 2) were intact and were assessed to be
large normal healthy follicles. On the other hand, granu-
losa cell layers were exfoliated and the theca internal of
cystic follicles were thinner than those of normal follicles
(Panel B in Figure 2), and were assessed as late stage cystic
follicles.
The ratios of estradiol-17β/progesterone for three of four
cystic follicles were below 1, and those of all normal folli-
cles were above 1 (Table 1).
FFs from normal follicles were generally palish yellow to
yellow and those from cystic follicles were dark yellow
and fulvescent. This suggested interfusion of blood into
the FF of cystic follicles. The total protein contents in FFs
are shown in Table 1. Although the number of samples
was limited, there was no particular tendency in the con-
tents of proteins, irrespective of cysts.
We compared the differential expression of proteins by 2-
D PAGE of FFs from cystic and normal follicles. Silver
staining detected about 30–40 protein spots on images
from both normal and cystic follicles (Panel A and Bs in
Silver stained 2-D PAGE images of proteins from bovine ovarian follicular fluidFigure 1
Silver stained 2-D PAGE images of proteins from bovine ovarian follicular fluid. Sample type A; Non treatment, Sample B; 
Depleted of impurities (salt, lipids, detergent and nuclei acid), Sample C; Depleted of abundant proteins (albumin and immu-
noglobulin G) and impurities.Page 4 of 9
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image of normal follicles, while small spots of minor pro-
teins were not detected on panel A of Figure 3. On the
other hand, there were about 30 spots on the image of
cystic follicles, and these included about 10 minor pro-
teins spots on panels B1 and B2 as shown in Figure 3.
Most of these spots were clumped in a square area on pan-
els B1 and B2. An image comparison using PDQuest
showed 8 increased protein spots were stably present on
the all cystic FF gels (Panel C in Figure 3). All 8 spots were
digested and forwarded to MALDI-TOF MS analysis for
protein identification. Database searching with peptide
mass fingerprinting by MALDI-TOF-MS/MS analysis iden-
tified the protein from spots No. 1 to 8 as BMFA, EAF,
MeS, VEGF-receptor, GAPDH, HSP70, BLG and SD (Table
2), respectively. Although the molecular weight and isoe-
lectric point of HSP70 calculated from the reported pri-
mary structure differed from those extrapolated by the
position of the spot on the gel, it was confirmed by MS/
MS amino acid sequence analysis that the protein from
spot No. 6 was HSP70.
Discussion
It is reported that bovine FF includes abundant protein,
such as albumin and IgG [19]. Mortarino et al. [18] car-
ried out 2-D PAGE on the FF of BOFC, which was not
depleted of these abundant proteins, so they overlooked
some spots of minor, but important proteins. Therefore,
the effect of removing abundant protein and impurities,
such as salts, lipids, detergent and nucleic acid, from FF on
Light micrographs of bovine ovarian follicles stained with hematoxylin and eosinFi ure 2
Light micrographs of bovine ovarian follicles stained with hematoxylin and eosin. [A] Normal follicle, approximately 10 mm in 
diameter with granulosa. [B] Cystic follicle, approximately 30 mm in diameter with theca interna, but without granulosa. G: 
granulosa layer, TI: theca interna, TE: theca externa. Bar = 50 µm...
Table 1: Concentrations of estradiol-17β and progesterone, and protein content in the follicular fluid of cystic and normal follicles
Concentration (ng/mL) of Estradiol-17β/
progesterone
Protein content (mg/mL)
Estradiol-17β Progesterone
Normal (n = 3) 150.3 ± 115.8 57.5 ± 57.9 3.09 ± 2.85 87.6a
Cystic (n = 4) 59.4 ± 108.5 284.7 ± 181.8* 0.80 ± 1.55 83.1 ± 9.7
All data are expressed as mean ± standard error except for protein contents of normal follicles
a Protein content was measured using a pooled sample of three normal follicles.
* Value of cystic FF is significantly different from value of normal FF (p < 0.05)Page 5 of 9
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Spota Identified protein Nominal mass (Mr) Calculated pI value Number of matched 
peptides
Sequence coverage 
(%)b
1 Bovine mitochondrial f1-atpase 13558 10.09 3 17
2 Erythroid associated factor 10711 4.82 2 26
3 Methionine synthase 14618 6.1 3 35
4 VEGF-receptor (Fragment) 17481 4.52 3 34
5 Glyceraldehydes 3-phosphate 
dehydrogenase (Fragment)
16813 9.21 3 33
6 Heat-Shock Cognate 70 kd Protein 
44 kd Atpase N-Terminal Mutant 
With Cys 17 Replaced By Lys
41580.5 7.8 4 14
7 β-lactoglobulin 18156 4.84 4 36
8 Succinate dehydrogenase Ip subunit 16176 5.87 4 33
a The numbers correspond to the spot number on the gel shown in Figure 4.
Representative silver stained 2-DPAGE images of proteins from normal follicles [A] and cystic follicles [B1 & B2]Figure 3
Representative silver stained 2-DPAGE images of proteins from normal follicles [A] and cystic follicles [B1 & B2]. Protein sam-
ples from both types of follicles were depleted of both abundant proteins (albumin and IgG) and impurities. Expressions of pro-
tein spots on the images from cystic and normal FFs which were processed for 2-D PAGE were simultaneously compared, and 
the results compared using each image image. Panel C is an enlarged image of square areas in panel B1, which contained some 
additional protein spots of cystic follicles.Page 6 of 9
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obtain satisfactory 2-D PAGE images for differential pro-
teomics. The quality of the 2-D PAGE images was
improved and the number of visualized spots increased
by removing abundant proteins, such as albumin and IgG
from FF, as well as other body fluids, serum [22,23], cere-
brospinal fluid [24] and bile [25], and by removing
impediments, such as salts, nucleic acid and lipids, for the
isoelectric focusing process [26] in this study. Concomi-
tant to the removal of albumin and IgG, there was a sig-
nificant enhancement in the staining intensity of several
lower abundance protein spots. This indicates that 2-D
PAGE using refined FF is a useful experimental tool for
research on the physiology of FF in the ovaries of farm and
experimental animals.
The sample ovarian follicles used in this study were exam-
ined morphologically and endocrinologically. The diam-
eters of cystic follicles were greater than 25 mm by
macroscopic observation; the granulosa cell layers were
already exfoliated and the theca internals of some cystic
follicles were thinner than those of healthy follicles. These
observations show that the follicles examined in this
study were late stage cystic follicles [1,27-29]. Non-domi-
nant regressing cystic follicles showed lower estradiol-17β
concentrations and higher progesterone concentrations
compare to normal follicles or dominant cystic follicles,
so that the ratio of estradiol-17β/progesterone of non-
dominant regressing cystic follicles was below 1 [30]. The
ratios of estradiol-17β/progesterone of three of four cystic
follicles in this study were below 1 and these values are
consistent with the histological examination, i.e. that
these follicles were late stage cystic follicles.
This study was designed to identify the specific proteins in
the FF of BOFC in order to help clarify the pathology of
BOFC using 2-D PAGE. We found 8 additional protein
spots on the gel from the cystic follicles compared with
the normal control, and these proteins were identified as
BMFA, EAF, MeS, VEGF-receptor, GAPDH, HSP70, BLG
and SD using the MOLDI-TOF MS technique.
Heat shock proteins (HSPs) are encoded by genes whose
expression is substantial during stressful conditions, such
as heat shock, inhibition of energy metabolism, exposure
to heavy metals, oxidative stress, and inflammation
[31,32]. Under these conditions, HSPs increase cell sur-
vival by protecting and disaggregating stress-labile pro-
teins. Under no-stress conditions, HSPs have multiple
housekeeping functions, such as folding and translocating
newly synthesized proteins [32,33]. It was confirmed that
HSP70 was clearly expressed in the granulosa cells of
human ovaries in vitro [34], and was synthesized by
oocytes and cumulus cells in cows [35], and by granulosa
cells within follicles in rats [36]. HSPs play an important
role in fertilization and early embryonic development
[37-39]. Recently, the ability to inhibit apoptosis has
become widely recognized as a function of HSP70, and
this ability may contribute to its protective effect against
cell death [39-42]. HSP70 inhibits apoptosis and this
effect may be ascribed to its neutralizing interactions with
several proapoptotic effectors [40]. Isobe and Yoshimura
[43] reported that in the theca interna of bovine ovarian
follicles, a high frequency of apoptosis was noted in the
early cystic follicles, whereas this frequency decreased in
late cystic follicles. They concluded that the decrease in
the rate of cell apoptosis may be responsible for the delay
in follicular regression, and that control of apoptosis may
be essential for reducing the incidence of cystic follicles.
This observation is consistent with our result that HSP70,
which decreases apoptotic cell death, was increased in the
FF of cystic follicles. Peter [3] emphasized that under-
standing the mechanisms that regulate granulosa cell
growth, differentiation and apoptosis is of great clinical
importance because aberrant signalling in any of these
pathways is likely to be related to in cystic ovaries. HSP70
might be the key protein related to apoptosis in granulosa
cells. It is thought that cows with follicular cysts are
exposed to various kinds of stress such as oxidative stress
[29], negative energy balance, poor liver function and low
circulating insulin-like growth factor-I [44]. Although the
relationship between these stresses and the increase in
HSP70 in FF in this study is unclear, it is speculated that
over-expression of HSP70 decreases apoptosis in the theca
interna and leads to delayed regression of cystic follicles
which had prevented ovulation due to hormonal
imbalance.
VEGF is known as a hypoxia-inducible mitogen for
endothelial cells [45], and is also referred to as a vascular
permeability factor [46], affecting vasodilatation and cap-
illary permeability and stimulating endothelial cell
growth and angiogenesis in vivo. VEGF and its receptors
have been found in the ovaries of numerous species
including bovine, ovine, porcine and monkey ovaries,
and may be important regulators of ovarian angiogenesis
[47]. In humans, VEGF is implicated in the etiology of
serious reproductive disorders such as polycystic ovary
syndrome, and in this syndrome, elevated VEGF may
interact with its receptors, such as Flk-1/KDR, in the
affected ovaries, preventing granulosa cell apoptosis and
the resultant follicle atresia, thus contributing to the
growth and persistence of a large number of follicles [45].
Isobe et al. [48] reported that the numbers of positive ves-
sels and areas with von Willebrand factor, an indicator of
endothelial damage, were significantly reduced in the
theca of follicles in association with the cyst development.
This suggested that fewer degenerative changes in the vas-
culature occur in BOFC, which allows a consistent blood
supply and may result in maintaining follicular tissue sta-Page 7 of 9
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in receptors of VEGF, which is well known as a mitogen
for endothelial cells and a vascular permeability factor, in
the present study may have been associated with abnor-
mal follicular growth via a steady blood supply and accu-
mulation of FF originating from serum in the BOFC.
BMFA is the water-soluble component of ATP synthase,
and the enzyme plays a central role in energy transforma-
tion in most living organisms [49]. SD is a key enzyme
involved in both the tricarboxylic acid cycle and oxidative
phosphorylation as part of the mitochondrial respiratory
chain [50]. MeS is an important cellular housekeeping
enzyme [51] and methionine is the most limiting amino
acid for growing cattle [52]. Therefore, fluctuations in
amino acids or energy metabolism in cows with cystic fol-
licles may lead to increased BMFA, SD and MeS. However,
there is no specific information on the three proteins or
EAF, GDP and BLG in ovarian physiology, follicular devel-
opment and/or regression, and the exact relationship
between cystic follicles and these proteins remains to be
clarified.
The majority of proteins identified in the follicular fluid of
cystic follicles in the present study were not the type of fac-
tors one would expect to find secreted into follicular fluid;
they were predominantly intracellular proteins. Isobe and
Yoshimura [43] reported that apoptotic sells in the granu-
losa layer were observed in cystic follicles, and granulosa
cell layers were also exfoliated in this study. Therefore,
these intracellular proteins might be passed into the FF
from the degenerated granulosa layer. On the other hand,
the cystic follicular fluids used in this study were dark yel-
low and fulvescent, suggesting interfusion of blood into
the FF of cystic follicles, and EAF was increased in cystic
FF. Thus, the possibility that these proteins came via
blood cannot be ruled out. Further investigations regard-
ing the source of these proteins and the mechanism by
which they entered the FF are needed.
Conclusion
In conclusion, although we mainly examined late stage
cysts and it may be only one scene of complicated BOFC
formation, we identified 8 increased proteins in the FF of
BOFC using 2D-PAGE and the MOLDI-TOF MS tech-
nique. Our results suggest that these proteins play impor-
tant roles in the etiology of BOFC, and that over-
expression of HSP70 may contribute to delaying follicular
regression by decreasing apoptosis in the theca interna,
and over- expression of VEGF-receptors may be associated
with abnormal follicular growth and accumulation of FF.
Furthermore, the 8 proteins found in the FF could be used
as biomarkers for ovarian cysts. Further studies are needed
to clarify the pathology and etiology of BOFC including
the examination of the source of these proteins, their
interaction, the relationship between these proteins and
ovarian physiology, and FF from various stages of folli-
cles, including atretic follicles and dominant cysts.
Authors' contributions
JM was responsible for the design, coordination of the
study and experiments He performed hormonal
measurements, 2D-PAGE, and protein identification, par-
ticipated in the analysis of data and in drafting the manu-
script. SI collaborated in the MOLDI-TOF MS analysis and
protein identification. NI collaborated in the hormonal
measurements and histological examinations. TT was
responsible for design and coordination of the study. He
analyzed the data and drafted the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We are grateful to the staff of the Meat Inspection Office of Hiroshima city 
for supplying the bovine ovaries. We also thank Mr. Matthew Man, Astra-
Zeneca KK, for his English proofreading of the manuscript.
References
1. Kesler DJ, Garverick HA: Ovarian cysts in dairy cattle: a review.
J Anim Sci 1982, 55:1147-1159.
2. Kawate N: Mechanism of ovarian cyst formation in ruminants.
J Jpn Vet Med Assoc 2001, 54:79-84.
3. Peter AT: An update on cystic ovarian degeneration in cattle.
Reprod Dom Anim 2004, 39:1-7.
4. Garverick HA: Ovarian follicular cysts in dairy cows.  J Dairy Sci
1997, 80:995-1004.
5. Farin PW, Estill CT: Infertility due to abnormalities of the ova-
ries in cattle.  Vet Clin North Am Food Anim Pract 1993, 9:291-308.
6. Silvia WJ, Hatler TB, Nugent AM, Laranja da Fonseca LF: Ovarian
follicular cysts in dairy cows: an abnormality in
folliculogenesis.  Domest Anim Endocrinol 2002, 23:167-77.
7. Cook DL, Parfet JR, Smith CA, Moss GE, Youngquist RS, Garverick
HA: Secretory patterns of LH and FSH during development
and hypothalamic and hypophysial characteristics following
development of steroid-induced ovarian follicular cysts in
dairy cattle.  J Reprod Fertil 1991, 91:19-28.
8. Hamilton SA, Garverick HA, Keisler DH, Xu ZZ, Loos K, Youngquist
RS, Salfen BE: Characterization of ovarian follicular cysts and
associated endocrine profiles in dairy cows.  Biol Reprod 1995,
53:890-898.
9. Yoshioka K, Iwamura S, Kamomae H: Changes of ovarian struc-
tures, plasma LH, FSH, progesterone and estradiol-17 beta
in a cow with ovarian cysts showing spontaneous recovery
and relapse.  J Vet Med Sci 1998, 60:257-60.
10. Odore R, Re G, Badino P, Donn A, Vigo D, Biolatti B, Girardi C: Mod-
ifications of receptor concentrations for adrenaline, steroid
hormones, prostaglandin F2alpha and gonadotropins in
hypophysis and ovary of dairy cows with ovarian cysts.  Phar-
macol Res 1999, 39:297-304.
11. Elmore RG: Using GnRH, HCG, and anterior pituitary
extracts in bovine hormonal therapy.  Vet Med 1989,
84:214-216.
12. O'Farrell PH: High resolution two-dimensional electrophore-
sis of proteins.  J Biol Chem 1975, 250:4007-4021.
13. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber
R, Weiss W: The current state of two-dimensional electro-
phoresis with immobilized pH gradients.  Electrophoresis 2000,
21:1037-1053.
14. Thongboonkerd V: Proteomics in nephrology: current status
and future directions.  Am J Nephrol 2004, 24:360-378.
15. Blackstock WP, Weir MP: Proteomics: quantitative and physical
mapping of cellular proteins.  Trends Biotechnol 1999, 17:121-127.
16. Chambers G, Lawrie L, Cash P, Murray GI: Proteomics: a new
approach to the study of disease.  J pathol 2000, 192:280-288.Page 8 of 9
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:23 http://www.rbej.com/content/3/1/23Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
17. Toda T, Satoh M, Sugimoto M, Goto M, Furuichi Y, Kimura N: A
comparative analysis of the proteins between the fibroblasts
from Werner's syndrome patients and age-matched normal
individuals using two-dimensional gel electrophoresis.  Mech
Ageing Dev 1998, 100:133-143.
18. Mortarino M, Vigo D, Maffeo G, Ronchi S: Two-dimensional poly-
acrylamide gel electrophoresis map of bovine ovarian fluid
proteins.  Electrophoresis 1999, 20:866-869.
19. Muranaka K, Moriyoshi M, Nakao T, Kawata K: Chemical compo-
nents of bovine follicular fluid and peripheral blood serum.  J
Coll Dairying 1986, 11:423-435.
20. Isobe N, Nakao T, Yamashiro H, Shimada M: Enzyme immu-
noassay of progesterone in the feces from beef cattle to
monitor the ovarian cycle.  Anim Reprod Sci 2005, 87(1-2):1-10.
21. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric
sequencing of proteins from silver-stained polyacrylamide
gels.  Anal Chem 1996, 68:850-858.
22. Ahmed N, Barker G, Oliva K, Garfin D, Talmadge K, Georgiou H,
Quinn M, Rice G: An approach to remove albumin for the pro-
teomic analysis of low abundance biomarkers in human
serum.  Proteomics 2003, 3:1980-1987.
23. Sellers TA, Yates JR: Review of proteomics with applications to
genetic epidemiology.  Genet Epidemiol 2003, 24:83-98.
24. Wenner BR, Lovell MA, Lynn BC: Proteomic analysis of human
ventricular cerebrospinal fluid from neurologically normal,
elderly subjects using two-dimensional LC-MS/MS.  J Proteome
Res 2004, 3:97-103.
25. Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ,
Argani P, Goggins MG, Maitra A, Pandey A: A proteomic analysis
of human bile.  Mol Cell Proteomics 2004, 3:715-728.
26. Hirsch J, Hansen KC, Burlingame AL, Matthay MA: Proteomics:
current techniques and potential applications to lung
disease.  Am J Physiol Lung Cell Mol Physiol 2004, 287:L1-L23.
27. Lopez-Diaz MC, Bosu WTK: A review and an update of cystic
ovarian degeneration in ruminants.  Theriogenology 1992,
37:1163-1183.
28. Eyestone WH, Ax RL: A review of ovarian follicular cysts in
cows, with comparisons to the condition in women, rats and
rabbits.  Theriogenology 1984, 22:109-125.
29. Kamomae H, Iwamura S, Yoshioka K, Taniguchi T, Sato M, Tanaka S,
Nagasawa S, Shiono H, Takahashi Y, Ohashi T, Motoi Y, Hiramatsu M:
Clinico-endocrinological, biochemical and histopathological
analyses on ovarian cyst in cow.  Tohoku J Vet Clin 1995, 18:55-64.
30. Calder MD, Manikkam M, Salfen BE, Youngquist RS, Lubahn DB, Lam-
berson WR, Garverick HA: Dominant bovine ovarian follicular
cysts express increased levels of messenger RNAs for lutein-
izing hormone receptor and 3β-hydroxysteroid dehydroge-
nase ∆4, ∆5 isomerase compared to normal dominant
follicles.  Biol Reprod 2001, 65:471-476.
31. Zylicz M, King FW, Wawrzynow A: Hsp70 interactions with the
p53 tumour suppressor protein.  EMBO J 2001, 20:4634-46348.
32. Jolly C, Morimoto RI: Role of the heat shock response and
molecular chaperones in oncogenesis and cell death.  J Natl
Cancer Inst 2000, 92:1564-1572.
33. Helmbrecht K, Zeise E, Rensing L: Chaperones in cell cycle regu-
lation and mitogenic signal transduction: a review.  Cell Prolif
2000, 33:341-365.
34. Benifla JL, Sifer C, Bringuier AF, Blanc-Layrac G, Camus E, Madelenat
P, Feldmann G: Induced apoptosis and expression of related
proteins in granulosa cells from women undergoing IVF: a
preliminary study.  Hum Reprod 2002, 17:916-920.
35. Edwards JL, Hansen PJ: Differential responses of bovine oocytes
and preimplantation embryos to heat shock.  Mol Reprod Dev
1997, 46:138-145.
36. Yoon SJ, Choi KH, Lee KA: Nitric oxide-mediated inhibition of
follicular apoptosis is associated with HSP70 induction and
Bax suppression.  Mol Reprod Dev 2002, 61:504-510.
37. Al-Katanani YM, Hansen PJ: Induced thermotolerance in bovine
two-cell embryos and the role of heat shock protein 70 in
embryonic development.  Mol Reprod Dev 2002, 62:174-180.
38. Kawarsky SJ, King WA: Expression and localisation of heat
shock protein 70 in cultured bovine oocytes and embryos.
Zygote 2001, 9:39-50.
39. Matwee C, Kamaruddin M, Betts DH, Basrur PK, King WA: The
effects of antibodies to heat shock protein 70 in fertilization
and embryo development.  Mol Hum Reprod 2001, 7:829-37.
40. Garrido C, Schmitt E, Cande C, Vahsen N, Parcellier A, Kroemer G:
HSP27 and HSP70: potentially oncogenic apoptosis
inhibitors.  Cell Cycle 2003, 2:579-584.
41. Gurbuxani S, Schmitt E, Cande C, Parcellier A, Hammann A, Daugas
E, Kouranti I, Spahr C, Pance A, Kroemer G, Garrido C: Heat shock
protein 70 binding inhibits the nuclear import of apoptosis-
inducing factor.  Oncogene 2003, 22:6669-6678.
42. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N,
Mak T, Jaattela M, Penninger JM, Garrido C, Kroemer G: Heat-
shock protein 70 antagonizes apoptosis-inducing factor.  Nat
Cell Biol 2001, 3:839-843.
43. Isobe N, Yoshimura Y: Localization of apoptotic cells in the
cystic ovarian follicles of cows: a DNA-end labeling histo-
chemical study.  Theriogenology 2000, 53:897-904.
44. Zulu VC, Sawamukai Y, Nakada K, Kida K, Moriyoshi M: Relation-
ship among insulin-like growth factor-I, blood metabolites
and postpartum ovarian function in dairy cows.  J Vet Med Sci
2002, 64:879-885.
45. Greenaway J, Connor K, Pedersen HG, Coomber BL, LaMarre J,
Petrik J: Vascular endothelial growth factor and its receptor,
Flk-1/KDR, are cytoprotective in the extravascular compart-
ment of the ovarian follicle.  Endocrinology 2004, 145:2896-2905.
46. Plendl J: Angiogenesis and vascular regression in the overy.
Anat Histol Embryol 2000, 29:257-266.
47. Reynolds LP, Redmer DA: Expression of the angiogenic factors,
basic fibroblast growth factor and vascular endothelial
growth factor, in the ovary.  J Anim Sci 1998, 76:1671-1681.
48. Isobe N, Yoshimura Y, Nakao T: Distribution of immunoreactive
von Willebrand factor in the microvascular network of
bovine cystc follicle.  Anim Sci J 2002, 73:123-129.
49. Menz RI, Walker JE, Leslie AG: Structure of bovine mitochon-
drial F(1)-ATPase with nucleotide bound to all three cata-
lytic sites: implications for the mechanism of rotary catalysis.
Cell 2001, 106:331-341.
50. Favier J, Briere JJ, Strompf L, Amar L, Filali M, Jeunemaitre X, Rustin
P, Gimenez-Roqueplo AP: Hereditary Paraganglioma/Pheo-
chromocytoma and Inherited Succinate Dehydrogenase
Deficiency.  Horm Res 2005, 63:171-179.
51. Chen Z, Chakraborty S, Banerjee R: Demonstration that mam-
malian methionine synthases are predominantly cobalamin-
loaded.  J Biol Chem 1995, 270:19246-19249.
52. Lambert BD, Titgemeyer EC, Stokka GL, DeBey BM, Loest CA:
Methionine supply to growing steers affects hepatic activities
of methionine synthase and betaine-homocysteine methyl-
transferase, but not cystathionine synthase.  J Nutr 2002,
132:2004-2009.Page 9 of 9
(page number not for citation purposes)
